MagForce AG Installs NanoActivator® at the Kiel University Hospital

MagForce AG / MagForce AG Installs NanoActivator® at the Kiel University Hospital . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement. Berlin, Germany, December 19, 2013 - MagForce AG (Frankfurt, Xetra: MF6), a medical technology company that focuses on the field of oncology and is a leader in the nanotechnology sector, today announced the installation of the third NanoActivator(®). The NanoActivator(®) was installed as part of the preparations for the new glioblastoma study at the Kiel University Hospital. About MagForce AG' MagForce AG is a leading medical device company in the field of nanomedicine in oncology, listed in the entry standard (MF6). The Company's proprietary, NanoTherm(®) therapy, enables the targeted treatment of solid tumors through the intratumoral generation of heat via activation of superparamagnetic nanoparticles. NanoTherm(®), NanoPlan(®), and NanoActivator(®) are components of the therapy and have received EU-wide regulatory approval as medical devices for the treatment of brain tumors. MagForce, NanoTherm(®), NanoPlan(®), and NanoActivator(®) are trademarks of MagForce AG in selected countries. For more information, please visit Disclaimer This release may contain forward-looking statements and information which may be identified by formulations using terms such as "expects", "aims", "anticipates", "intends", "plans", "believes", "seeks", "estimates" or "will". Such forward- looking statements are based on our current expectations and certain assumptions, which may be subject to a variety of risks and uncertainties. The results actually achieved by MagForce AG may substantially differ from these forward-looking statements. MagForce AG assumes no obligation to update these forward-looking statements or to correct them in case of developments, which differ from those, anticipated. For further information: Anne Hennecke MC Services AG T +49 211 529252 22 F  +49 211 529252 29 M +49 151 12 555 759 MagForce_Press Release_December 19, 2013: This announcement is distributed by GlobeNewswire on behalf of GlobeNewswire clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: MagForce AG via GlobeNewswire [HUG#1751288]